Empowering Development and Enabling Seamless Assay Transfer

Exploratory and preclinical studies often require rapid development of assays. In creating novel immunoassays or providing cellular-based analysis, researchers must proactively plan for a transition to CAP/CLIA or GxP facility for qualification, method validation and implementation. These case studies showcase a number of challenging, high-profile projects supported by the Labcorp Drug Development Translational Biomarker Solutions (Labcorp Drug Development TBS) team.

Copy and paste this URL:

https://drugdevelopment.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/casestudies/Empowering-Development-Enabling-Seamless-Assay-Transfer-CSBMRK003.pdf